European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
Community Register of medicinal products
Community register of orphan medicinal products | GRANTED |
Product information |
Tasimelteon
| EU orphan designation number: | EU/3/10/841
|
| Active ingredient: | Tasimelteon |
| Indication: | Treatment of non-24-hour sleep-wake disorders in blind people with no light perception |
| Sponsor: | Vanda Pharmaceuticals Limited
C/O Regus Management (UK) Limited, 81 Oxford Street, London W1D 2EU, United Kingdom |
Public summary of scientific opinion
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 01/03/2011 | Centralised Orphan - Designation | EMA/OD/102/10 | (2011)1307 of 23/02/2011 |